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Introduction
Depression and anxiety disorders are highly prevalent, cause great suffering and disability, and have a large impact on society (Murphy et al., 2004; Wittchen et al., 2011; Buist-Bouwman et al., 2006; Murray & Lopez, 1997b; Murray & Lopez, 1997a) .
Fortunately, several effective psycho-and pharmacotherapeutic treatments are widely applied for these disorders (Cuijpers et al., 2013) . However, they place a high demand on healthcare services (Gustavsson et al., 2011; Nutt, 2011; Smit et al., 2006) . Offering these treatments in a more concise form without compromising effectiveness might mitigate this problem (Cape et al., 2010) . In this paper, we report the clinical results of a pragmatic, randomized controlled equivalence trial. This entails comparing concise and standard care. We tested the hypothesis thatconcise care is 'as effective as' standard care delivered in a secondary outpatient setting. We focused on patients with mild to moderate illness severity because we assumed that since in most cases their illness is less complicated, they would react more favorable to a concise approach. In both conditions, patients are treated with psycho-and/or pharmacotherapy delivered in routine practice.
However, in concise care the treatments are limited in time and in number of (weekly) sessions (maximum 7) and offered as first (brief) step in a stepped-care model (Haaga, 2000; Davison, 2000) . Standard care is not confined to a maximum number of sessions or limited time-period (van Fenema et al., 2012) . Patient characteristics and treatment effectiveness are assessed with Routine Outcome Monitoring (ROM; de Beurs et al., 2011) , a standard monitoring procedure already in use in the participating outpatient clinics. We hypothesized that concise care is equally effective as (equivalent to) standard care 3, 6 and 12 months after baseline assessment.
Methods
The methods were published previously (Meuldijk et al., 2012) and are summarized briefly here. The Medical Ethics Committee (MEC) of the Leiden University Medical Center (LUMC) approved the study. It involved a comprehensive protocol (titled "Psychiatric Academic Registration Leiden database") which safeguarded the anonymity of patients and participants and ensured proper handling of the data. We followed consolidated standards for reporting randomised controlled equivalence trials (Hopewell et al., 2008; Moher et al., 2010; Piaggio et al., 2012) . All participants provided written informed consent before study entry.
Study design and participants
A two-armed pragmatic randomised controlled equivalence trial was conducted at five outpatient Mental Health Clinics (MHCs). These clinics were part of Rivierduinen (RD), a secondary Regional Mental Health Provider (RHMP) in the province of South-Holland, the Netherlands. Eligible participants were patients referred to the MHCs by their general practitioners (GP), aged 18-65 years, and meeting the DSM IV-TR criteria for a primary current diagnosis of anxiety disorder and/or depression, established using the MiniInternational Neuropsychiatric Interview-Plus, version 5.0.0 (MINI-Plus; Sheehan et al., 1998; van Vliet & de Beurs, 2007) . For a list of included diagnoses see Appendix A, Table I . Excluded were patients with suicidal or homicidal risk, severe social dysfunction, delusions, hallucinations and/or suffering from bipolar or psychotic disorders. Other comorbidity with psychiatric disorders was allowed. The inclusion (and exclusion) criteria for enrolling subjects in this study enduced a study sample of patients suffering from mild to moderate anxiety and/or depressive disorders (APA, 1994) . Insufficient mastery of Dutch was a reason for exclusion. Experienced psychiatrists at the MHCs determined study eligibility (Meuldijk et al., 2012) . Eligible participants were randomly assigned to concise or standard care and assessed by ROM at baseline (T 1 ), 3 (T 2 ), 6 (T 3 ) and 12 (T 4 ) months thereafter.
Randomisation and masking
A block randomisation scheme, stratified by MHC (n = 5) and gender was used.
Randomisation was carried out by one of the researchers (D.M.). Patients and therapists
were informed about the outcome; the psychiatric test nurses responsible for the ROM assessments were not (Meuldijk et al., 2012) .
Treatment
The treatment protocols in both conditions followed the Dutch and international guidelines for the evidence-based treatment of depressive and anxiety disorders. In both concise and standard care, a choice could be made between pharmacotherapy with a selective serotonin reuptake inhibitor (SSRI; (Guy, 1976) , Cognitive Behavioural Therapy (CBT; Clark & Salkovskis, 1987; Beck, 1995; Clark & Salkovskis, 1987) and, in case of a posttraumatic stress disorder, Eye Movement Desensitization and Reprocessingtherapy (EMDR; Shapiro, 1995) . A combination of pharmaco-and psychotherapy was also possible. In standard care the number of sessions, start and duration of treatment is variable and treatment could continue during the entire study period of 1 year. On average, psychotherapy is provided in 3-6 months on a weekly basis, but in practice once every 2 to 3 weeks, pharmacotherapy for 1 year or longer (van Fenema et al., 2012) . In contrast, concise care started within one week after the baseline measurement and had to be given within 7 weeks thereafter. Concise care was initially described as 4 to maximum 7 individual 45-minute psychotherapy sessions, depending on the treatment protocol (see also Meuldijk et al. 2012) . The pharmacotherapy protocol for depressive and/anxiety disorders in concise care was confined to a maximum of 4 sessions within 7 weeks.
Moreover, therapists' treatment choice in both standard and concise care followed the principles of shared decision-making (Hamann et al. 2003; Joosten et al. 2008 ). Contrary to standard care, treatment goals and procedures in concise care are clearly established and mutually agreed on, prior to initiating treatment. In addition, treatment success of concise care was evaluated at the end of treatment. When either the patient or therapist is convinced that the clinical effects are insufficient or patients are insufficiently helped by the initial treatments in concise care, 'stepping up' or continuation of (additional) standard treatment, in line with stepped-care principles, was possible (Haaga, 2000; Davison, 2000) . Pharmacotherapy in concise care was also evaluated after 7 weeks, and continued when necessary according to the (inter) national clinical guidelines. After implementation changes to the treatment protocols were made at the recommendation of the MHCs; these included extending the treatment duration of concise care to a maximum of 7 sessions in 7-9 weeks. This was to allow treatment continuation of concise care in case of canceled or missed sessions by therapists or patients.
Therapists providing concise care received a 2 hours instruction in the core elements of the intensified psychotherapy and/or pharmacotherapy, as described in the protocols.
Therapists in the standard condition did not get additional training (Meuldijk et al., 2012) .
The same therapists were responsible for delivering standard and concise care. All sessions in concise care were audiotaped for post-hoc assessment of treatment fidelity.
Sufficient treatment protocol-adherence (>75%) was demonstrated in a random sample of 20 patients with a satisfactory overall agreement between two independent raters (Cohen's Kappa: 0.74).
Measures

Routine Outcome Monitoring (ROM)
ROM is a computer-based system to routinely assess symptom severity and functioning with an extensive battery of psychometric instruments. ROM is administered as part of the intake procedure (at baseline) and repeatedly during and after treatment (de Beurs et al.(de Beurs et al., 2011) . In the present trial, measures of participants characteristics were collected at baseline, while symptom measures were administered at each time point (see also Meuldijk et al., 2012 ). An overview of ROM instruments at the different timepoints, is given in Appendix A, Table 2 .
Outcomes
The Brief Symptom Inventory (BSI; (Derogatis, 1975) and the Web Screening Questionnaire (WSQ (Donker et al., 2009 ) constituted the primary outcome measures in this study. The secondary measures used were the Clinical Global Impression (CGI (Guy, 1976 ) and the Short-Form-36 Health Survey (SF-36; (Ware et al., 1993; Aaronson et al., 1998) . Additionally, patients satisfaction with their care was explored by The Dutch
Mental Healthcare Thermometer of Appreciation by Clients ( (Kok & van, 2003) .
Primary outcomes
Brief Symptom Inventory (BSI; (Derogatis, 1975) . This patient-rated, 53 item questionnaire which is based on the Symptom Checklist (SCL-90 (Derogatis & Melisaratos, 1983 ) assesses psychopathological symptom severity on a 5-point Likert scale (from 0 'not at all' to 4 'extremely'). The BSI total score, most indicative of general psychopathology, was computed as the mean score of all individual items (range 0-4).
Web Screening Questionnaire (WSQ; (Donker et al., 2009) . This is a self-rated, 15 item questionnaire which is based on the screening questionnaire (SQ) of Marks and colleagues. It is used as a quick tool to screen patients for most common mental disorders (Gega et al., 2005) . The WSQ has 8 'yes' or 'no' answers, the other 7 are Likert-type scales. Response was defined as a score above the pre-specified threshold for being diagnosed with any particular WSQ diagnosis (Donker et al., 2009 ).
Secondary outcomes
Clinical Global Impression (CGI; (Guy, 1976) This is a clinician rated scale that assesses illness severity. The main item 'severity of illness' measured on a 7-point Likert scale
(from 1 'normal, not at all ill' to 7 'among the most extremely ill patients') is used in the present analyses.
The Short Form-36 Health Survey (SF-36; (Ware et al., 1993; Aaronson et al., 1998) . This self-report questionnaire assesses current general health status and quality of life in eight domains (36 items). Measurement scales vary per subscale, ranging from yes/no to answers on 3-, 5-, or 6-point Likert scale. All raw scores are linearly converted to a 0-100 subscale, with higher scores representing better functioning/quality of life.
In this paper, we report the changes in scores on the three SF-36 subscales which are primarily indicative of physical and mental health (Ware et al. 1994; : physical functioning, social functioning and general health. (Kok & van, 2003) . The thermometer contains 18 items; 17 items with 'yes' or 'no' answers, and one question on 'overall satisfaction with care', (scores from 1 to 5, higher scores indicating more satisfaction). Two additional items with an open answer format were not included here.
The Dutch Mental Healthcare Thermometer of Appreciation by Clients
Equivalence margins
The study was designed to demonstrate therapeutical equivalence between concise and standard care and follows study procedures already published in Meuldijk et al. 2012 .
The sample size calculation (see (Meuldijk et al., 2012) indicated that 500 patients (alpha=0·05, 1 -β=0·80, two-sided) were required to demonstrate equivalence (Jones et al., 1996) . Concise care will be deemed equivalent to standard care, if the 95% confidence interval (CI) for the observed difference in the proportions of treatment success (defined as a 50% reduction in BSI score compared to baseline BSI score) do not cross these predefined clinical margins of equivalence (∆) of -15% and + 15% including an acceptable difference of 5% (Meuldijk et al., 2012; Wiens, 2002; Jones et al., 1996) .
The equivalence margins are specified a priori on the basis of a clinical notion of detection, a minimally clinically important difference in effect (see Meuldijk et al.2012) .
If the treatment effects of concise and standard care differ by more than this equivalence margin in either direction, then equivalence does not hold.
Although not powered for, we similarly evaluated equivalence for WSQ remission (defined as a score below the pre-specified threshold for being diagnosed with any WSQ diagnosis) at 6 and 12 months' measurements. We performed both intention-to-treat analyses and sensitivity analyses on the per protocol population (patients who completed both the baseline and the subsequent measurement) to test therapeutic equivalence.
Statistical analysis
We used descriptive statistics for the comparison of the baseline demographic and clinical variables between the groups that completed the treatment (completer group) and the group as randomised; t-tests were used for continuous measures and chi-square tests for categorical data. The margins of the 95% CIs on the basis of the observed difference in the proportions of treatment success of the primary outcomes were compared with the pre-determined equivalence margins. Equivalence was tested in both the intention-totreat and per protocol population.
Additionally, Generalized Estimating Equation (GEE) models (Zeger & Liang, 1986; Twisk, 2004) were used to estimate the mean differences between treatment groups and the confidence intervals (CIs) at each assessment point for both primary and secondary continuous outcomes; odds ratios with 95% CIs were given for dichotomous outcomes and differences in means for continuous outcomes. Since our GEE models yields odds ratios as the effect measure instead of risk ratios, effect-sizes are not presented.
For all GEE analyses, the predictor variables were: time (baseline (T 1 ) as reference, versus 3 (T 2 ), 6 (T 3 ) and 12 month (T 4 ) measurement); treatment group (concise care versus standard care), and interaction between time and treatment group. An unstructured correlation matrix was specified in the GEE model to account for the within-patient correlation (repeated, longitudinal observations).
To investigate if results were overly optimistic due to drop-out of those with less favorable outcome, GEE analyses were repeated with imputation of missing data, by carrying the last observation forward method. Patient satisfaction was explored by between-group comparisons of two sample t-tests for continuous variables. GEE analyses for both primary and secondary outcomes were on an intention-to-treat basis using IBM SPSS version 20 (Windows). Significance for all statistical tests was set at a p-value < 0.05 (two-sided). (see Figure 1 ), respectively n = 65 and n = 42 had outcome data.
Results
Randomisation
Descriptive statistics
The socio-demographic and clinical characteristics of the randomised sample and patients who completed both the baseline and the 3-month measurement (completer sample) are summarized in Table 1 . Demographic data were available for 178 patients (98%). The MINI-Plus was administered in 181 patients (99%).
 Insert Table 1 disorder(s). Comorbidity between anxiety and depression was found in 17% (31 patients).
34 patients (19%) did not pass the threshold for having any current Axis-I DSM-IV-TR diagnosis according to the MINI-Plus interview. These patients did seek professional help for their (subthreshold) depressive and/or anxiety complaints or symptoms.
Treatment received
During the entire study-period, 47 (25%) of all 182 patients, did not enter treatment (concise care, n = 24 of 93; standard care, n = 23 of 89). The majority of patients (61%) started treatment within 3 months after the baseline assessment (concise care, n = 63 (91%); standard care n = 48 (73%)). The majority of these patients were offered psychotherapy (concise care, n = 49 (78%); standard care n = 37 (77%)). Only a small number of patients were offered pharmacotherapy (concise care, n = 4 (6%); standard care, n = 6 (13%)) or a combination of both therapies (concise care n = 10 (16%); standard care n = 5 (10%)). In addition, with concise care, the number of therapy sessions (i.e. face to face contacts) was on average as prescribed in the treatment protocols: six sessions for psychotherapy and one for pharmacotherapy. Compared with standard care, the number of therapy sessions did not differ significantly (all P values > 0.05). Patients in the standard care group had on average three psychotherapy and one pharmacotherapy sessions (face to face contacts), within the first 3 months after baseline assessment. After the initial 3 months, 18 (27%) of the patients in standard care and 7 (10%) of the patients allocated to concise care actually started treatment. The number of patients who remitted or continued treatment after 12 months is unknown. No adverse events were reported. Table 2 presents the mean differences in the proportions of treatment success of BSI and WSQ and 95% CIs for both treatment groups over time for the intention-to-treat and the per protocol analysis.
Equivalence: BSI and WSQ
 Insert Table 2 here
The results of Table 2 analyses showed that the difference in BSI scores between groups was the largest 3 months after baseline and in favor of concise care (see Appendix B, Table 1 ).
 Insert Figure 3 here
Secondary outcomes
Mean secondary outcomes scores during treatment for both groups are presented in Figure 4 . The Clinical Global Impression scores reduced over time. Likewise, general health and quality of life improved in both treatment groups. GEE analyses showed statistically significant differences in effectiveness 3 and 12 months after baseline assessment in favor of concise care (see Appendix B, Table 2 ).
 Insert Figure 4 here
All analyses using imputation with last observation carried forward for the missing data yielded similar results. Since randomization had been successful, we did not explore all possible confounders. Adjusting for age and gender did not influence the differences between the concise and standard care group for any of the primary or secondary outcomes (data not shown).
Satisfaction with treatment. Patient satisfaction with treatment was measured 3 months
after baseline in 81 patients (missing data in 23 patients). On average, patients in the concise treatment group (n = 41) were more satisfied with overall treatment than patients in standard care (mean item difference 1.04; p = 0.024). Satisfaction with the therapist did not differ significantly between groups (p = 0.205).
Discussion
In this study we demonstrated that a novel 7-sessions concise version of cognitive behavioural therapy and/or pharmacotherapy led to comparable clinical outcomes as the longer standard care in the treatment of depressive and/or anxiety disorders in secondary care outpatients. This was true at the end of concise care at 3 months, but also later at 6
and 12 months and for all effect parameters. In fact, in concise care, the clinical effects are obtained earlier, in the first phase of treatment. Moreover, patients were more satisfied with treatment in concise care.
These results are in line with other studies on the effectiveness of brief treatments for depressive and anxiety disorders (Cape et al., 2010; Nieuwsma et al., 2011; van Straten et al., 2006; Ehlers et al., 2014 Therapists and patients had a central role in treatment. They were asked to strictly following the treatment protocols and actively participate in the study. Besides, prior to starting therapy, treatment goals were formulated and mutually agreed on by both the patient and therapist. These facts, could have also impacted the treatment outcome of concise care. Clinicians and patients could be highly motivated, contributing to this positive treatment effect.
Our study is one of the first to demonstrate these effects in secondary mental health care.
Treatment was provided in a regular 'real life' psychiatric outpatient sample by qualified therapists already working in the participating MHCs, reflecting day-to-day clinical practice. This increases external validity, thereby enhancing the generalizability of the results to clinical practice. Moreover, our study has good internal validity as is demonstrated by the successful randomization of the treatment groups, the sufficient treatment fidelity and delivery of treatment according to protocols. However, several potential methodological concerns have to be noted. Firstly, the desired sample size of 500 patients was not achieved. An investigation of the inclusion during a 2 month period showed that the majority of patients seeking treatment at the MHCs did not meet the trial inclusion criteria of our study because of the higher severity and burden of disease.
Secondly, a substantial number of patients did not complete treatment or were lost to assessment, a common problem in long-term studies in naturalistic out-patient settings (van Noorden et al., 2012; Rush et al., 2006; van Straten et al., 2006) .
However, although we did not achieve the intended sample size of 500 patients we did find concise care to be at least as effective as concise care. Contrary to our initial expectations and assumptions of a real difference in percentages success between the treatments of 5% in either direction, the observed difference between the two treatments was larger than expected; e.g. 13% in favor of concise care in the intention-to-treat population at three months for the primary outcome measure BSI. The observed differences in success percentages at the three time points all being in favor of concise turned out to be sufficient to compensate for the loss to follow-up of patients. Another limitation is that because of the pragmatic study design, patient's suitability to participate in the trial during the course of the study was assessed by the therapists involved.
Unfortunately, the reasons for excluding patients from care during the trial were not adequately reported. Due to this lack of knowledge, we cannot make any statements about post-randomisation drop-out and reasons for loss to follow-up after study entry.
However, concise care, as such, did not increase dropout rates significantly when compared to standard care. In both groups a comparable number of patients had to be excluded, dropped out or did not visit the clinic as scheduled. We found no evidence for selective attrition on baseline characteristics, and our conservative handling of missing data, with last observations carried forward, did not alter the patterns of outcomes. An additional limitation, associated with the pragmatic study design, was that in practice, treatment and therapist adherence to the protocols in concise care was not optimal; not all patients were offered concise care as prescribed in the treatment protocols. Moreover, the design of the study as a RCT in a pragmatic setting resulted in considerable differences in follow-up periods between patients and groups. Although the majority of patients were offered concise care within the first 3 months after study entry, the duration of concise care was prolonged and continued during the entire study period (i.e. therapy sessions in concise care were delivered in 7-9 weeks). However, it appears that concise care did a better job of engaging patients in treatment in a more timely manner. This is reflected in the higher patient satisfaction rating for concise care reported at 3 months. In conclusion,
we found that concise care is equally effective as standard care in the secondary outpatient treatment of depressive-and/or anxiety disorders. The early start of concise care, the strict scheduling of weekly patient-therapist contacts and the ongoing monitoring of treatment outcome are important for the beneficial effects of the concise treatment. Since concise care is likely to provide significant health gain, and most beneficial effects are obtained within the first phase of treatment, concise care is recommended as first step in a stepped-care delivery of care. Moreover, in contrast to other studies, concise care examined here follows a stratified stepped-care approach taking into account patients' needs and preferences which may be clinically more adequate than the more stringent model of stepped-care which begins with the least intensive treatment for each patient regardless of the patients needs and circumstances.
Because the study was carried out in a naturalistic setting, the generalizability of the results is good. The study population reflects the subgroup of lighter cases referred to secondary care, therefore the findings of our study are generalizable to a broader patient population. However, the problems with the inclusion of patients and the high drop-out rate may decrease the generalizability, but these problems are also very difficult to avoid in a naturalistic setting. We hope that future studies with a larger sample size, longer follow-up and more strict adherence to the study protocol, will confirm our promising findings.
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Intention-to-treat
Standard care
Concise CGI: Clinical Global Impression; SF-36: Short-Form Health Survey (SF-36 higher scores representing better functioning/quality of life).
